You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
滿貫集團(03390.HK)擬2000萬港元入股雅各臣科研製藥旗下品牌保健護理公司
格隆匯 07-27 17:40

格隆匯 7 月 27日丨滿貫集團(03390.HK)發佈公告,2020年7月27日,認購方(景柏有限公司,公司的間接全資附屬公司)、目標控股公司(JBM Group (BVI) Limited)及目標公司(JBM (Healthcare) Limited,目標控股公司的全資附屬公司)訂立認購協議,據此,認購方同意認購,而目標公司同意按總認購價現金2000萬港元配發及發行認購股份。

根據認購協議,於目標戰略投資及目標附屬公司重組完成後,認購股份預計將佔目標公司經配發及發行認購股份及根據目標戰略投資及目標附屬公司重組向其他投資者配發及發行其他目標股份擴大的經擴大已發行股本約2.36%。

目標公司為一間於開曼羣島註冊成立的投資控股有限公司。目標集團主要從事品牌保健護理業務,包括品牌藥、品牌中藥以及品牌健康及保健產品(如保健品、個人護理產品以及健康診斷套件)。

目標控股公司為雅各臣科研製藥(02633.HK)的全資附屬公司。於該公告日期,目標控股公司的同系附屬公司持有公司已發行股份約7.07%及集團與目標控股公司的若干同系附屬公司進行各類業務合作,包括作為集團供應商及共同投資於並非集團成員公司的公司。

公告表示,目標集團主要從事品牌保健護理業務,包括品牌藥、品牌中藥以及品牌健康及保健產品(如保健品、個人護理產品以及健康診斷套件)。董事認為,認購事項將加強其與目標集團的戰略關係,可使集團獲得更廣泛的產品組合,進一步增強集團作為大健康及生活相關產品供應商的能力及競爭力,並提升集團供應商及連鎖零售商客户分別作為其分銷商及供應鏈合作伙伴的信心。此外,董事認為,認購事項可為集團提供透過投資於目標集團產生潛在投資回報的機會。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account